Lipid mediators and allergic diseases

Annals of Allergy, Asthma and Immunology

Volumn 111, Issue 3, 2013, Pages 155-162

  Fanning, Laura B ^a   Boyce, Joshua A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (1 HYDROXYHEXYL)PHENYL] 5 OXOCYCLOPENTANEHEPTANOIC ACID; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 7,8 DIHYDRO 5 [2 [[ALPHA (3 PYRIDYL)BENZYLIDENE]AMINOOXY]ETHYL] 1 NAPHTHYLOXYACETIC ACID; ARACHIDONATE 5 LIPOXYGENASE; CICAPROST; DICLOFENAC; ILOPROST; INDOMETACIN; LEUKOTRIENE B4; LIPID; OC 000459; ONO AE1 329; OZAGREL; PEPTIDOLEUKOTRIENE; PLACEBO; PREDNISONE; PROSTACYCLIN; PROSTACYCLIN RECEPTOR; PROSTAGLANDIN D2; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR AFFECTING AGENT; PROSTAGLANDIN SYNTHASE; PROSTANOID; RAMATROBAN; SERATRODAST; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR; TM 30089; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ALLERGIC DISEASE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHOSPASM; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; EOSINOPHILIC ESOPHAGITIS; HUMAN; MEDIATOR RELEASE; MODERATE PERSISTENT ASTHMA; NONHUMAN; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIGNAL TRANSDUCTION; TH2 CELL; TREATMENT OUTCOME;

ANIMALS; HUMANS; HYPERSENSITIVITY; LIPIDS; LIPOXYGENASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 84883451929     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.06.031     Document Type: Article

References (108)

1. T. Shimizu Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation Annu Rev Pharmacol Toxicol 49 2009 123 150
2. R.H. Schaloske, and E.A. Dennis The phospholipase A2 superfamily and its group numbering system Biochim Biophys Acta 1761 2006 1246 1259
3. Y.J. Kang, U.R. Mbonye, C.J. DeLong, M. Wada, and W.L. Smith Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation Prog Lipid Res 46 2007 108 125
4. B.L. Diaz, and J.P. Arm Phospholipase A(2) Prostaglandins Leukot Essent Fatty Acids 69 2003 87 97
5. W.L. Smith, and R. Langenbach Why there are two cyclooxygenase isozymes J Clin Invest 107 2001 1491 1495
6. T.D. Warner, and J.A. Mitchell Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic FASEB J 18 2004 790 804
7. T. Hirata, and S. Narumiya Prostanoids as regulators of innate and adaptive immunity Adv Immunol 116 2012 143 174
8. D.C. Zeldin, C. Wohlford-Lenane, and P. Chulada Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide Am J Respir Cell Mol Biol 25 2001 457 465
9. M.A. Carey, D.R. Germolec, and J.A. Bradbury Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/- mice Am J Respir Crit Care Med 167 2003 1509 1515
10. J. Nakata, M. Kondo, and J. Tamaoki Augmentation of allergic inflammation in the airways of cyclooxygenase-2-deficient mice Respirology 10 2005 149 156
11. J.W. Card, M.A. Carey, and J.A. Bradbury Cyclooxygenase-1 overexpression decreases Basal airway responsiveness but not allergic inflammation J Immunol 177 2006 4785 4793
12. R.S. Peebles Jr., R. Dworski, and R.D. Collins Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice Am J Respir Crit Care Med 162 2000 676 681
13. R.S. Peebles Jr., K. Hashimoto, and J.D. Morrow Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice Am J Respir Crit Care Med 165 2002 1154 1160
14. L. Swedin, T. Neimert-Andersson, and J. Hjoberg Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice Eur Respir J 34 2009 200 208
15. M.C. Liu, E.R. Bleecker, and L.M. Lichtenstein Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma Am Rev Respir Dis 142 1990 126 132
16. M.C. Liu, D. Proud, and L.M. Lichtenstein Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects J Allergy Clin Immunol 108 2001 29 38
17. J.E. Fish, M.G. Ankin, N.F. Adkinson Jr., and V.I. Peterman Indomethacin modification of immediate-type immunologic airway responses in allergic asthmatic and non-asthmatic subjects: evidence for altered arachidonic acid metabolism in asthma Am Rev Respir Dis 123 1981 609 614
18. J.G. Kirby, F.E. Hargreave, D.W. Cockcroft, and P.M. O'Byrne Effect of indomethacin on allergen-induced asthmatic responses J Appl Physiol 66 1989 578 583
19. L.J. Roberts II, B.J. Sweetman, R.A. Lewis, K.F. Austen, and J.A. Oates Increased production of prostaglandin D2 in patients with systemic mastocytosis N Engl J Med 303 1980 1400 1404
20. K. Tanaka, K. Ogawa, K. Sugamura, M. Nakamura, S. Takano, and K. Nagata Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets J Immunol 164 2000 2277 2280
21. Y. Urade, M. Ujihara, Y. Horiguchi, K. Ikai, and O. Hayaishi The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues J Immunol 143 1989 2982 2989
22. R.G. Townley, and S. Agrawal CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils Ann Allergy Asthma Immunol 109 2012 365 374
23. K. Honda, M. Arima, and G. Cheng Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine J Exp Med 198 2003 533 543
24. Y. Fujitani, Y. Kanaoka, K. Aritake, N. Uodome, K. Okazaki-Hatake, and Y. Urade Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice J Immunol 168 2002 443 449
25. H. Hammad, H.J. de Heer, T. Soullie, H.C. Hoogsteden, F. Trottein, and B.N. Lambrecht Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1 J Immunol 171 2003 3936 3940
26. H. Hammad, M. Kool, and T. Soullie Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells J Exp Med 204 2007 357 367
27. I. Spik, C. Brenuchon, and V. Angeli Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse J Immunol 174 2005 3703 3708
28. L. Uller, J.M. Mathiesen, and L. Alenmyr Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation Respir Res 8 2007 16
29. J.J. Murray, A.B. Tonnel, and A.R. Brash Release of prostaglandin D2 into human airways during acute antigen challenge N Engl J Med 315 1986 800 804
30. R.M. Naclerio, H.L. Meier, and A. Kagey-Sobotka Mediator release after nasal airway challenge with allergen Am Rev Respir Dis 128 1983 597 602
31. D. Proud, J. Sweet, and P. Stein Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen J Allergy Clin Immunol 85 1990 896 905
32. S.L. Johnston, N.J. Freezer, W. Ritter, S. O'Toole, and P.H. Howarth Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor Eur Respir J 8 1995 411 415
33. T.R. Martin, N.P. Gerard, S.J. Galli, and J.M. Drazen Pulmonary responses to bronchoconstrictor agonists in the mouse J Appl Physiol 64 1988 2318 2323
34. N. Barnes, I. Pavord, and A. Chuchalin A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma Clin Exp Allergy 42 2012 38 48
35. F. Horak, P. Zieglmayer, and R. Zieglmayer The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial Allergy 67 2012 1572 1579
36. D. Singh, P. Cadden, and M. Hunter Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 Eur Respir J 41 2013 46 52
37. A. Straumann, S. Hoesli, and C. Bussmann Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis Allergy 68 2013 375 385
38. W.W. Busse, S.E. Wenzel, and E.O. Meltzer Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients J Allergy Clin Immunol 131 2013 339 345
39. R.M. Breyer, C.K. Bagdassarian, S.A. Myers, and M.D. Breyer Prostanoid receptors: subtypes and signaling Annu Rev Pharmacol Toxicol 41 2001 661 690
40. J.M. Hartney, K.G. Coggins, and S.L. Tilley Prostaglandin E2 protects lower airways against bronchoconstriction Am J Physiol Lung Cell Mol Physiol 290 2006 L105 L113
41. J.R. Sheller, D. Mitchell, B. Meyrick, J. Oates, and R. Breyer EP(2) receptor mediates bronchodilation by PGE(2) in mice J Appl Physiol 88 2000 2214 2218
42. T. Kunikata, H. Yamane, and E. Segi Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3 Nat Immunol 6 2005 524 531
43. T. Liu, T.M. Laidlaw, and C. Feng Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation Proc Natl Acad Sci U S A 109 2012 12692 12697
44. G.M. Gauvreau, R.M. Watson, and P.M. O'Byrne Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation Am J Respir Crit Care Med 159 1999 31 36
45. I.D. Pavord, C.S. Wong, J. Williams, and A.E. Tattersfield Effect of inhaled prostaglandin E2 on allergen-induced asthma Am Rev Respir Dis 148 1993 87 90
46. E. Melillo, K.L. Woolley, P.J. Manning, R.M. Watson, and P.M. O'Byrne Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects Am J Respir Crit Care Med 149 1994 1138 1141
47. P. Sestini, L. Armetti, and G. Gambaro Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma Am J Respir Crit Care Med 153 1996 572 575
48. T.G. Brock Regulating leukotriene synthesis: the role of nuclear 5-lipoxygenase J Cell Biochem 96 2005 1203 1211
49. J. Buckley, M.A. Birrell, S.A. Maher, A.T. Nials, D.L. Clarke, and M.G. Belvisi EP4 receptor as a new target for bronchodilator therapy Thorax 66 2011 1029 1035
50. C. Benyahia, I. Gomez, and L. Kanyinda PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy? Pulm Pharmacol Ther 25 2012 115 118
51. L.J. Kay, W.W. Yeo, and P.T. Peachell Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation Br J Pharmacol 147 2006 707 713
52. M. Okano, Y. Sugata, and T. Fujiwara E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2 Immunology 118 2006 343 352
53. W. Zhou, K. Hashimoto, and K. Goleniewska Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells J Immunol 178 2007 702 710
54. W. Zhou, T.S. Blackwell, and K. Goleniewska Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells J Leukoc Biol 81 2007 809 817
55. S. Toki, K. Goleniewska, and M.M. Huckabee PGI2 signaling inhibits antigen uptake and increases migration of immature dendritic cells J Leukoc Biol 94 2013 77 88
56. Y. Takahashi, S. Tokuoka, and T. Masuda Augmentation of allergic inflammation in prostanoid IP receptor deficient mice Br J Pharmacol 137 2002 315 322
57. K. Nagao, H. Tanaka, M. Komai, T. Masuda, S. Narumiya, and H. Nagai Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice Am J Respir Cell Mol Biol 29 2003 314 320
58. C. Yamabayashi, T. Koya, and H. Kagamu A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice Am J Respir Cell Mol Biol 47 2012 170 177
59. E. Majeski, A. Hoskins, R. Dworski, and J.R. Sheller Iloprost inhalation in mild asthma J Asthma 49 2012 961 965
60. M. Fujimura, S. Ozawa, and T. Matsuda Effect of oral administration of a prostacyclin analog (OP-41483) on pulmonary function and bronchial responsiveness in stable asthmatic subjects J Asthma 28 1991 419 424
61. B.J. Whittle, and S. Moncada Pharmacological interactions between prostacyclin and thromboxanes Br Med Bull 39 1983 232 238
62. T. Hirata, F. Ushikubi, A. Kakizuka, M. Okuma, and S. Narumiya Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation J Clin Invest 97 1996 949 956
63. A. Zarbock, K. Singbartl, and K. Ley Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation J Clin Invest 116 2006 3211 3219
64. H. Shi, A. Yokoyama, and N. Kohno Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice Eur Respir J 11 1998 624 629
65. I.K. Taylor, P.S. Ward, and K.M. O'Shaughnessy Thromboxane A2 biosynthesis in acute asthma and after antigen challenge Am Rev Respir Dis 143 1991 119 125
66. M.D. Lupinetti, J.R. Sheller, F. Catella, and G.A. Fitzgerald Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation Am Rev Respir Dis 140 1989 932 935
67. K. Sladek, R. Dworski, and G.A. Fitzgerald Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin Am Rev Respir Dis 141 1990 1441 1445
68. H. Aizawa, H. Inoue, and H. Nakano Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics Prostaglandins Leukot Essent Fatty Acids 59 1998 185 190
69. M. Hoshino, J. Sim, K. Shimizu, H. Nakayama, and A. Koya Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma J Allergy Clin Immunol 103 1999 1054 1061
70. H. Kunitoh, K. Watanabe, A. Nagatomo, H. Okamoto, and T. Nakagawa A double-blind, placebo-controlled trial of the thromboxane synthetase blocker OKY-046 on bronchial hypersensitivity in bronchial asthma patients J Asthma 35 1998 355 360
71. K. Sladek, R. Dworski, and J. Soja Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge Am J Respir Crit Care Med 149 1994 940 946
72. T.M. Laidlaw, and J.A. Boyce Cysteinyl leukotriene receptors, old and new; implications for asthma Clin Exp Allergy 42 2012 1313 1320
73. J.A. Mancini, and J.F. Evans Cloning and characterization of the human leukotriene A4 hydrolase gene Eur J Biochem 231 1995 65 71
74. J. Maclouf, C. Antoine, P.M. Henson, and R.C. Murphy Leukotriene C4 formation by transcellular biosynthesis Ann N Y Acad Sci 714 1994 143 150
75. T.M. Laidlaw, M.S. Kidder, and N. Bhattacharyya Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes Blood 119 2012 3790 3798
76. C.G. Irvin, Y.P. Tu, J.R. Sheller, and C.D. Funk 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice Am J Physiol Lung Cell Mol Physiol 272 1997 L1053 L1058
77. B.B. Vargaftig, and M. Singer Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR Am J Physiol Lung Cell Mol Physiol 285 2003 L808 L818
78. W.R. Henderson Jr., D.B. Lewis, and R.K. Albert The importance of leukotrienes in airway inflammation in a mouse model of asthma J Exp Med 184 1996 1483 1494
79. C. Mondino, G. Ciabattoni, and P. Koch Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children J Allergy Clin Immunol 114 2004 761 767
80. I.D. Pavord, R. Ward, G. Woltmann, A.J. Wardlaw, J.R. Sheller, and R. Dworski Induced sputum eicosanoid concentrations in asthma Am J Respir Crit Care Med 160 1999 1905 1909
81. A.P. Sampson, D.P. Castling, C.P. Green, and J.F. Price Persistent increase in plasma and urinary leukotrienes after acute asthma Arch Dis Child 73 1995 221 225
82. P.E. Christie, P. Tagari, and A.W. Ford-Hutchinson Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects Am Rev Respir Dis 143 1991 1025 1029
83. E. Israel, J. Cohn, L. Dube, and J.M. Drazen Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group JAMA 275 1996 931 936
84. M.C. Liu, L.M. Dube, and J. Lancaster Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group J Allergy Clin Immunol 98 1996 859 871
85. E. Israel, A.R. Fischer, and M.A. Rosenberg The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin Am Rev Respir Dis 148 1993 1447 1451
86. A. Di Gennaro, and J.Z. Haeggstrom The leukotrienes: immune-modulating lipid mediators of disease Adv Immunol 116 2012 51 92
87. A.P. Sampson FLAP inhibitors for the treatment of inflammatory diseases Curr Opin Investig Drugs 10 2009 1163 1172
88. Y. Kanaoka, A. Maekawa, and K.F. Austen Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand J Biol Chem 288 2013 10967 10972
89. Y. Kanaoka, and J.A. Boyce Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses J Immunol 173 2004 1503 1510
90. A.R. Sousa, A. Parikh, G. Scadding, C.J. Corrigan, and T.H. Lee Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis N Engl J Med 347 2002 1493 1499
91. D.C. Kim, F.I. Hsu, and N.A. Barrett Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation J Immunol 176 2006 4440 4448
92. N.A. Barrett, O.M. Rahman, and J.M. Fernandez Dectin-2 mediates Th2 immunity through the generation of cysteinyl leukotrienes J Exp Med 208 2011 593 604
93. N.A. Barrett, J.M. Fernandez, and A. Maekawa Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation J Immunol 189 2012 4556 4565
94. Y. Jiang, L.A. Borrelli, Y. Kanaoka, B.J. Bacskai, and J.A. Boyce CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells Blood 110 2007 3263 3270
95. W.R. Henderson Jr., L.O. Tang, and S.J. Chu A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model Am J Respir Crit Care Med 165 2002 108 116
96. J.W. Weiss, J.M. Drazen, and N. Coles Bronchoconstrictor effects of leukotriene C in humans Science 216 1982 196 198
97. J.W. Weiss, J.M. Drazen, and E.R. McFadden Jr. Comparative bronchoconstrictor effects of histamine, leukotriene C, and leukotriene D in normal human volunteers Trans Assoc Am Physicians 95 1982 30 35
98. A.B. Davidson, T.H. Lee, and P.D. Scanlon Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects Am Rev Respir Dis 135 1987 333 337
99. P.E. Christie, M. Schmitz-Schumann, B.W. Spur, and T.H. Lee Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects Eur Respir J 6 1993 1468 1473
100. P. Montuschi, and M.L. Peters-Golden Leukotriene modifiers for asthma treatment Clin Exp Allergy 40 2010 1732 1741
101. M. Peters-Golden, M.M. Gleason, and A. Togias Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis Clin Exp Allergy 36 2006 689 703
102. M. Morgan, and D.A. Khan Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1 Ann Allergy Asthma Immunol 100 2008 403 411
103. A.M. Tager, and A.D. Luster BLT1 and BLT2: the leukotriene B(4) receptors Prostaglandins Leukot Essent Fatty Acids 69 2003 123 134
104. K. Terawaki, T. Yokomizo, and T. Nagase Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses J Immunol 175 2005 4217 4225
105. C.R. Turner, R. Breslow, and M.J. Conklyn In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma J Clin Invest 97 1996 381 387
106. T.E. Liston, M.J. Conklyn, and J. Houser Pharmacokinetics and pharmacodynamics of the leukotriene B4 receptor antagonist CP-105,696 in man following single oral administration Br J Clin Pharmacol 45 1998 115 121
107. A. Hicks, R. Goodnow Jr., and G. Cavallo Effects of LTB4 receptor antagonism on pulmonary inflammation in rodents and non-human primates Prostaglandins Other Lipid Mediat 92 2010 33 43
108. A.D. Luster, and A.M. Tager T-cell trafficking in asthma: lipid mediators grease the way Nat Rev Immunol 4 2004 711 724